The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Artemisunate-Global Market Insights and Sales Trends 2025

Artemisunate-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1809842

No of Pages : 95

Synopsis
The global Artemisunate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artemisunate in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Artemisunate market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Industrial Grade segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Artemisunate market, driven by demand from China, the second largest economy with some signs of stabilising, the Artemisunate market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artemisunate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artemisunate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artemisunate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artemisunate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artemisunate covered in this report include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc.
The global Artemisunate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Global Artemisunate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artemisunate market, Segment by Type:
Pharmaceutical Grade
Industrial Grade
Global Artemisunate market, by Application
Malaria Treatment
Scientific Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artemisunate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artemisunate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Artemisunate Market Overview
1.1 Artemisunate Product Overview
1.2 Artemisunate Market Segment by Type
1.2.1 Pharmaceutical Grade
1.2.2 Industrial Grade
1.3 Global Artemisunate Market Size by Type
1.3.1 Global Artemisunate Market Size Overview by Type (2018-2029)
1.3.2 Global Artemisunate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artemisunate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artemisunate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artemisunate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artemisunate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artemisunate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artemisunate Sales Breakdown by Type (2018-2023)
2 Global Artemisunate Market Competition by Company
2.1 Global Top Players by Artemisunate Sales (2018-2023)
2.2 Global Top Players by Artemisunate Revenue (2018-2023)
2.3 Global Top Players by Artemisunate Price (2018-2023)
2.4 Global Top Manufacturers Artemisunate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artemisunate Market Competitive Situation and Trends
2.5.1 Artemisunate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artemisunate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artemisunate as of 2022)
2.7 Date of Key Manufacturers Enter into Artemisunate Market
2.8 Key Manufacturers Artemisunate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artemisunate Status and Outlook by Region
3.1 Global Artemisunate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artemisunate Historic Market Size by Region
3.2.1 Global Artemisunate Sales in Volume by Region (2018-2023)
3.2.2 Global Artemisunate Sales in Value by Region (2018-2023)
3.2.3 Global Artemisunate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artemisunate Forecasted Market Size by Region
3.3.1 Global Artemisunate Sales in Volume by Region (2024-2029)
3.3.2 Global Artemisunate Sales in Value by Region (2024-2029)
3.3.3 Global Artemisunate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artemisunate by Application
4.1 Artemisunate Market Segment by Application
4.1.1 Malaria Treatment
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Artemisunate Market Size by Application
4.2.1 Global Artemisunate Market Size Overview by Application (2018-2029)
4.2.2 Global Artemisunate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artemisunate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artemisunate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artemisunate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artemisunate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artemisunate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artemisunate Sales Breakdown by Application (2018-2023)
5 North America Artemisunate by Country
5.1 North America Artemisunate Historic Market Size by Country
5.1.1 North America Artemisunate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artemisunate Sales in Volume by Country (2018-2023)
5.1.3 North America Artemisunate Sales in Value by Country (2018-2023)
5.2 North America Artemisunate Forecasted Market Size by Country
5.2.1 North America Artemisunate Sales in Volume by Country (2024-2029)
5.2.2 North America Artemisunate Sales in Value by Country (2024-2029)
6 Europe Artemisunate by Country
6.1 Europe Artemisunate Historic Market Size by Country
6.1.1 Europe Artemisunate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artemisunate Sales in Volume by Country (2018-2023)
6.1.3 Europe Artemisunate Sales in Value by Country (2018-2023)
6.2 Europe Artemisunate Forecasted Market Size by Country
6.2.1 Europe Artemisunate Sales in Volume by Country (2024-2029)
6.2.2 Europe Artemisunate Sales in Value by Country (2024-2029)
7 Asia-Pacific Artemisunate by Region
7.1 Asia-Pacific Artemisunate Historic Market Size by Region
7.1.1 Asia-Pacific Artemisunate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artemisunate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artemisunate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artemisunate Forecasted Market Size by Region
7.2.1 Asia-Pacific Artemisunate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artemisunate Sales in Value by Region (2024-2029)
8 Latin America Artemisunate by Country
8.1 Latin America Artemisunate Historic Market Size by Country
8.1.1 Latin America Artemisunate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artemisunate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artemisunate Sales in Value by Country (2018-2023)
8.2 Latin America Artemisunate Forecasted Market Size by Country
8.2.1 Latin America Artemisunate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artemisunate Sales in Value by Country (2024-2029)
9 Middle East and Africa Artemisunate by Country
9.1 Middle East and Africa Artemisunate Historic Market Size by Country
9.1.1 Middle East and Africa Artemisunate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artemisunate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artemisunate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artemisunate Forecasted Market Size by Country
9.2.1 Middle East and Africa Artemisunate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artemisunate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Artemisunate Products Offered
10.1.5 Sanofi Recent Development
10.2 KPC Pharmaceuticals
10.2.1 KPC Pharmaceuticals Company Information
10.2.2 KPC Pharmaceuticals Introduction and Business Overview
10.2.3 KPC Pharmaceuticals Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 KPC Pharmaceuticals Artemisunate Products Offered
10.2.5 KPC Pharmaceuticals Recent Development
10.3 Guangxi Xiancaotang Pharmaceutical
10.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
10.3.2 Guangxi Xiancaotang Pharmaceutical Introduction and Business Overview
10.3.3 Guangxi Xiancaotang Pharmaceutical Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Guangxi Xiancaotang Pharmaceutical Artemisunate Products Offered
10.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
10.4 Guilin Pharmaceutical
10.4.1 Guilin Pharmaceutical Company Information
10.4.2 Guilin Pharmaceutical Introduction and Business Overview
10.4.3 Guilin Pharmaceutical Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Guilin Pharmaceutical Artemisunate Products Offered
10.4.5 Guilin Pharmaceutical Recent Development
10.5 Kerui Nanhai Pharmaceutical
10.5.1 Kerui Nanhai Pharmaceutical Company Information
10.5.2 Kerui Nanhai Pharmaceutical Introduction and Business Overview
10.5.3 Kerui Nanhai Pharmaceutical Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kerui Nanhai Pharmaceutical Artemisunate Products Offered
10.5.5 Kerui Nanhai Pharmaceutical Recent Development
10.6 Shanghai Natural Bio-engineering Co
10.6.1 Shanghai Natural Bio-engineering Co Company Information
10.6.2 Shanghai Natural Bio-engineering Co Introduction and Business Overview
10.6.3 Shanghai Natural Bio-engineering Co Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shanghai Natural Bio-engineering Co Artemisunate Products Offered
10.6.5 Shanghai Natural Bio-engineering Co Recent Development
10.7 Novanat Bioresource
10.7.1 Novanat Bioresource Company Information
10.7.2 Novanat Bioresource Introduction and Business Overview
10.7.3 Novanat Bioresource Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novanat Bioresource Artemisunate Products Offered
10.7.5 Novanat Bioresource Recent Development
10.8 Botanical Extracts EPZ Ltd
10.8.1 Botanical Extracts EPZ Ltd Company Information
10.8.2 Botanical Extracts EPZ Ltd Introduction and Business Overview
10.8.3 Botanical Extracts EPZ Ltd Artemisunate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Botanical Extracts EPZ Ltd Artemisunate Products Offered
10.8.5 Botanical Extracts EPZ Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artemisunate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artemisunate Industrial Chain Analysis
11.4 Artemisunate Market Dynamics
11.4.1 Artemisunate Industry Trends
11.4.2 Artemisunate Market Drivers
11.4.3 Artemisunate Market Challenges
11.4.4 Artemisunate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artemisunate Distributors
12.3 Artemisunate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’